Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
Newborn infants with maternal-fetal ABO incompatibility are at a greater risk for developing subsequent significant hyperbilirubinemia, and therefore, prediction of probable risk factors, such as the degree of hemolysis, gains importance. In this study, we aimed to evaluate the effect of feta...
Saved in:
| Main Authors: | Sinem Akgül, Ayşe Korkmaz, Sule Yiğit, Murat Yurdakök |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2013-10-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/1542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ABO incompatibility: which one matters?
by: S Umit Sarıcı
Published: (2014-04-01) -
Riboflavin in the treatment of neonatal hyperbilirubinemia
by: M Yurdakök, et al.
Published: (1988-07-01) -
Does inhaled salbutamol before surfactant therapy have any beneficial effect?
by: H Tolga Çelik, et al.
Published: (2018-12-01) -
Fetal malnutrition and its impacts on neonatal outcome in preterm infants
by: Ayşe Korkmaz, et al.
Published: (2011-06-01) -
Comparison of demographic characteristics and haematological parameters in newborns with and without haemolytic disease due to ABO incompatibility
by: Kamil Sahin, et al.
Published: (2025-07-01)